PD-1, Camrelizumab Biosimilar (PDCD1, CD279)

Size

£512.00

SKU:: 591734
Purity:: Purified by Protein A/G affinity chromatography. ≥95%. Endotoxin: ≤0.75/mg (LAL)
Storage Conditions:: -20°C
Supplier:: United States Biological
Host:: Human
Immunogen:: Recombinant protein corresponding to human PD-1, expressed in CHO cells.
Format:: Supplied as a liquid in PBS, pH 7.5.
Extra Details:: Camrelizumab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin with an approximate molecular weight of 149kD Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 combined with Apatinib in treatment of ED-SCLC after failure of first line standard therapy). Applications: Suitable for use in Functional Assays. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.